Results 111 to 120 of about 10,324 (206)
Botulinum toxin treatment in glaucomatous patients: a pilot study [PDF]
PURPOSE: The purpose was to evaluate the efficacy of the treatment of iatrogenic entropion (IE), in patients affected by primary open angle glaucoma (POAG), by botulinum toxin injections (BTI).
CARLESIMO, Sandra Cinzia +5 more
core
The pathogenesis of blepharospasm
Blepharospasm is a focal dystonia characterized by involuntary tetanic contractions of the orbicularis oculi muscle, which can lead to functional blindness and loss of independent living ability in severe cases. It usually occurs in adults, with a higher
Lixia Zhu +5 more
doaj +1 more source
Challenging the Clostridium botulinum toxin type A (BoNT/A) with a selection of microorganisms by culture methods and extended storage of used vials to assess the loss of sterility [PDF]
In 2002, botulinum toxin type A (BoNT/A) was approved by the US Food and Drug Administration (FDA) for cosmetic use. However, there may be procedural differences between the ways in which a clinician handles, applies and stores the product compared to ...
Crean, Stjohn +4 more
core
Study of Acute Toxicity of a New Veterinary Drug for Inttrammary Introduction [PDF]
Preclinical studies of veterinary medicinal products are important and compulsory studies in the development of new dosage forms. The aim of preclinical research is to determine the toxic effect and therapeutic efficacy of the test substance-the future ...
Polova, Z. (Zhanna)
core
Research priorities in limb and task-specific dystonias [PDF]
Altenmüller, Eckart +13 more
core +2 more sources
Oromandibular Dystonia—Meige′s Syndrome: Report of a Rare Case with Review
Meige′s syndrome is a combination of two forma of dystonia; blepharospasm and oromandibular dystonia (OMD). Oromandibular dystonia (OMD) is a form of focal dystonia affecting head and neck region, including the lower face, jaw, tongue and larynx.
Siddharth Gupta, Basavaraj T Bhagwati
doaj
High Dose AbobotulinumtoxinA for Blepharospasm: A Case Report on the Safety and Efficacy of 500 Units of AbobotulinumtoxinA. [PDF]
Santoso K, Baghaei A, Dashtipour K.
europepmc +1 more source

